John Lebbos
Partner, Commercial Strategy Consulting
John Lebbos, MD is a Partner in Clarivate’s Commercial Strategy Consulting team.
He is currently a practice leader in Product and Market Opportunity Assessments & Strategy and has over 20 years of experience supporting clients with product and therapeutic area strategy, functional patient journey analysis, opportunity and market assessments, disease area analysis, sales forecasting, and portfolio planning/strategy.
Formerly a Vice President in DRG’s infectious disease syndicated research group, Dr. Lebbos led the Infectious Disease research team and has had over 20 years of experience conducting market analysis, opportunity assessments and prioritization and product strategy.
Dr. Lebbos received his medical degree from the University of Massachusetts. Prior to pursuing his medical degree, he attended Tufts University where he graduated summa cum laude in chemical engineering.
Latest news
Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026
London, U.K., January 28, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth…
Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources
Clarivate Nexus integrates academic content and services into the AI tools increasingly used by students and researchers, helping libraries and institutions remain central to trusted scholarship. LONDON, UK — January…